Oscar Health, Inc. (NYSE:OSCR) Receives $22.93 Consensus Price Target from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has received an average rating of “Moderate Buy” from the eight research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $22.93.

A number of research firms recently commented on OSCR. Piper Sandler reiterated an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $16.86 on Friday. The firm’s 50-day moving average price is $17.80 and its 200-day moving average price is $18.15. Oscar Health has a 52-week low of $7.29 and a 52-week high of $23.79. The company has a market cap of $4.17 billion, a PE ratio of -280.95 and a beta of 1.67. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.29) EPS. As a group, analysts anticipate that Oscar Health will post -0.01 EPS for the current year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now directly owns 140,648 shares of the company’s stock, valued at $2,530,257.52. This trade represents a 2.92 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. The trade was a 3.99 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 1,055,478 shares of company stock valued at $14,432,852 and have sold 194,569 shares valued at $3,433,319. Insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. Sei Investments Co. raised its holdings in shares of Oscar Health by 100.0% during the 1st quarter. Sei Investments Co. now owns 42,998 shares of the company’s stock worth $639,000 after acquiring an additional 21,497 shares in the last quarter. Vanguard Group Inc. lifted its position in Oscar Health by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after purchasing an additional 337,850 shares during the last quarter. American International Group Inc. grew its stake in shares of Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock worth $1,181,000 after buying an additional 1,009 shares in the last quarter. Quadrature Capital Ltd bought a new stake in shares of Oscar Health in the 1st quarter worth about $1,312,000. Finally, Price T Rowe Associates Inc. MD raised its position in shares of Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after buying an additional 2,409,160 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.